Identification of New Biomarkers of Low-Dose GH Replacement Therapy in GH-Deficient Patients

CONTEXT: GH secretion peaks at puberty and continues to be secreted in adulthood, albeit at a declining rate. Profound GH deficiency (GHD) in adults with pituitary disease is associated with symptoms that improve with GH substitution, but it is important to tailor the GH dose to avoid overtreatment....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Cruz-Topete, Diana, Jorgensen, Jens Otto L., Christensen, Britt, Sackmann-Sala, Lucila, Krusenstjerna-Hafstrøm, Thomas, Jara, Adam, Okada, Shigeru, Kopchick, John J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Endocrine Society 2011
Aiheet:
Endocrine Care
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3205513/
https://ncbi.nlm.nih.gov/pubmed/21543428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2011-0197
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia